This report presents evidence supporting proteomic tests for cancer and cardiovascular disease currently approved in the United States and proteomic tests that may be available in the near term.
Aug 26, 2021
Max Griswold is a policy researcher at RAND and a Ph.D. candidate at the Pardee RAND Graduate School. His research is focused on behavioral risk factors in epidemiology and policy, with a particular emphasis on alcohol use, substance use, gun violence, and high body-mass index.
Prior to joining RAND, Griswold was a senior research scientist at the Institute for Health Metrics and Evaluation and was a high school math teacher through Americorps. His work on alcohol use and global health has appeared in numerous academic journals, such as The Lancet and JAMA, and featured in major news outlets. He holds an M.A. in economics from the University of Texas at Austin and a B.S. in economics, philosophy, and math from the Ohio State University.
Griswold et al., "Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016," The Lancet, 392(10152), 2018
Mokhdad et al., "The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states," JAMA, 219(14), 2018
Griswold, Fullman, & Adolph, "Estimating Global Tourist Consumption of Alcohol," Forthcoming, 2020 (forthcoming)